NCT07175766Completed
Dachundou No Sugar Added Soymilk for Lipid Modulation
A Study on the Lipid-Modulating and Health Benefits of Dachundou No Sugar Added Soymilk in Humans
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
Cardiovascular disease is one of the leading causes of death worldwide, and high cholesterol is a major risk factor. Diet is known to play an important role in managing blood lipids. Soy milk is a common plant-based drink rich in protein and isoflavones, which may help lower cholesterol and improve heart health. This clinical trial will evaluate whether daily consumption of Dachundou No Sugar Added Soymilk can help reduce cholesterol levels in adults with elevated total cholesterol (≥200 mg/dL). A total of 50 participants aged 18-65 will be recruited. Participants will drink two bottles of soymilk per day (375 mL each, total 750 mL) for 8 weeks. During the study, researchers will measure cholesterol, blood pressure, body weight, waist circumference, and other health indicators. The results will help determine whether Dachundou No Sugar Added Soymilk can improve blood lipid levels and contribute to cardiovascular health.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 2 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- National Taiwan Sport University
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT07175766
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 15 Sept 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of dietary supplements or drugs affecting lipid metabolism within 1 month before study entry or during the study
Other illness
- Diagnosed with chronic diseases under medical treatment (e.g., hypertension, hyperlipidemia, diabetes, liver, kidney, gastrointestinal, cardiovascular disease, cancer)
- Cognitive impairment preventing informed consent or protocol compliance
- History of allergy to soy milk, oats, or gluten-containing products
Other
- Pregnant or lactating women
- Menopausal or postmenopausal women
Who the study is looking for
- Adults aged 18-65 years
- Fasting total cholesterol (TC) ≥200 mg/dL at both screening (week -2) and baseline (week 0)
- Non-smokers
- No alcohol abuse
- Able and willing to comply with study procedures, dietary restrictions, and follow-up visits
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan Sport University Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.